Preventing effect of 1.35% menthol for oxaliplatin induced neurotoxicity
Phase 2
- Conditions
- coorectal cancer
- Registration Number
- JPRN-UMIN000009655
- Lead Sponsor
- Aizawa Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Not provided
Exclusion Criteria
1) dificult to use menthol due to other skin trouble 2) uncontrollable symptom due to cancer 3) uncontrollable symptom due to adverse events 4) other reasons causing neurotoxicity 5) not apropriate to registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method